Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia

Acute myelogenous leukemia (AML) is a fatal blood cancer with high patient mortality. Daunorubicin and cytarabine are first‐line chemotherapy for AML, with bone marrow transplantation in most cases. Recently, cancer immunotherapy has been challenged in AML and leukemia‐niche myeloid cells are promis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Seok‐Beom, Kim, Jaehyun, Chung, Jee Young, Ra, Sehee, kim, Seong Su, Kim, Yong‐Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341080/
https://www.ncbi.nlm.nih.gov/pubmed/32670766
http://dx.doi.org/10.1002/advs.202000487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341080/
https://www.ncbi.nlm.nih.gov/pubmed/32670766
http://dx.doi.org/10.1002/advs.202000487

Ejemplares similares